Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 1.56 ▼ -0.03 (-1.89%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Geron Corp | GERN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.63% | 1.59 | 1.64 | 1.55 | 1.60 | 1.58 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.56 | 1.64 | 0.08 | 4.88% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,742 | 2,403,986 | $ 1.59 | $ 3,822,658 | 1,374,873 | 0.92 - 6.99 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:55:16 | 2 | $ 1.56 | USD |
Geron Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 299.59M | 188.42M | $ -27.02M | -0.15 | - | 183.52M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Geron News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GERN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.4 | 1.64 | 1.37 | 1.4935 | 2M | 0.19 | 13.57% |
| 1 Month | 1.41 | 1.64 | 1.32 | 1.4293 | 1M | 0.18 | 12.77% |
| 3 Months | 1.52 | 1.64 | 1.08 | 1.3433 | 2M | 0.07 | 4.61% |
| 6 Months | 1.54 | 2.14 | 1.08 | 1.5878 | 2M | 0.05 | 3.25% |
| 1 Year | 6.85 | 6.99 | 0.92 | 2.0539 | 4M | -5.26 | -76.79% |
| 3 Years | 2.23 | 6.99 | 0.92 | 2.9765 | 3M | -0.64 | -28.70% |
| 5 Years | 2.45 | 6.99 | 0.92 | 3.1245 | 3M | -0.86 | -35.10% |
Geron Description
| Geron Corp is a clinical stage biopharmaceutical company. Its focus is the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Imelstat is expected to directly obstruct malignant-cell proliferation. The company has an exclusive collaboration and license agreement with Janssen Biotech to develop and commercialize imetelstat worldwide for oncology and other human therapeutic uses. |
